The prevalence of chronic kidney disease (CKD) is increasing worldwide, and the mortality
rate continues to be unacceptably high. The biomarkers currently used in clinical practice …

In its early stages, symptoms of chronic kidney disease (CKD) are usually not apparent.
Significant reduction of the kidney function is the first obvious sign of disease. If diagnosed …

Chronic kidney disease (CKD), defined as the presence of albuminuria and/or reduction in
estimated glomerular filtration rate (eGFR)< 60 mL/min/1.73 m2, is considered a growing …

Chronic kidney disease (CKD), characterized as renal dysfunction, is recognized as a major
public health problem with high morbidity and mortality worldwide. Unfortunately, there are …

Chronic kidney disease (CKD) is part of a number of systemic and renal diseases and may
reach epidemic proportions over the next decade. Efforts have been made to improve …

Chronic kidney disease (CKD) has emerged as a major public health problem worldwide. It
frequently progresses to end-stage renal disease, which is related to very high cost and …

Chronic kidney disease (CKD) is an aging-related disorder that represents a major global
public health burden. Current biochemical biomarkers, such as serum creatinine and urinary …

Chronic kidney disease (CKD) is a major public health problem. The classification of CKD by
KDOQI and KDIGO and the routine eGFR reporting have resulted in increased identification …

The current unidimensional paradigm of kidney disease detection is incompatible with the
complexity and heterogeneity of renal pathology. The diagnosis of kidney disease has …

A critical issue in the management of chronic kidney disease (CKD) is to prevent patients
from the progression to end-stage kidney disease (ESKD), however, there is only limited …